ID   NCOA3_MOUSE             Reviewed;        1398 AA.
AC   O09000; Q9CRD5;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 2.
DT   22-JUL-2008, entry version 81.
DE   RecName: Full=Nuclear receptor coactivator 3;
DE            Short=NCoA-3;
DE            EC=2.3.1.48;
DE   AltName: Full=Thyroid hormone receptor activator molecule 1;
DE            Short=TRAM-1;
DE            Short=ACTR;
DE   AltName: Full=Receptor-associated coactivator 3;
DE            Short=RAC-3;
DE   AltName: Full=Amplified in breast cancer-1 protein homolog;
DE            Short=AIB-1;
DE   AltName: Full=Steroid receptor coactivator protein 3;
DE            Short=SRC-3;
DE   AltName: Full=CBP-interacting protein;
DE            Short=p/CIP;
DE            Short=pCIP;
GN   Name=Ncoa3; Synonyms=Aib1, Pcip, Rac3, Tram1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH CREBBP; ESR AND RARA.
RX   MEDLINE=97336097; PubMed=9192892; DOI=10.1038/42652;
RA   Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K.,
RA   Rosenfeld M.G.;
RT   "The transcriptional co-activator p/CIP binds CBP and mediates
RT   nuclear-receptor function.";
RL   Nature 387:677-684(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1360-1398.
RC   STRAIN=C57BL/6J; TISSUE=Embryonic stem cell;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   MEDLINE=20300909; PubMed=10823921; DOI=10.1073/pnas.120166297;
RA   Xu J., Liao L., Ning G., Yoshida-Komiya H., Deng C., O'Malley B.W.;
RT   "The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1)
RT   is required for normal growth, puberty, female reproductive function,
RT   and mammary gland development.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:6379-6384(2000).
RN   [4]
RP   INTERACTION WITH CARM1.
RX   MEDLINE=99316081; PubMed=10381882; DOI=10.1126/science.284.5423.2174;
RA   Chen D., Ma H., Hong H., Koh S.S., Huang S.-M., Schurter B.T.,
RA   Aswad D.W., Stallcup M.R.;
RT   "Regulation of transcription by a protein methyltransferase.";
RL   Science 284:2174-2177(1999).
RN   [5]
RP   METHYLATION BY CARM1.
RX   MEDLINE=21625315; PubMed=11701890; DOI=10.1126/science.1065961;
RA   Xu W., Chen H., Du K., Asahara H., Tini M., Emerson B.M., Montminy M.,
RA   Evans R.M.;
RT   "A transcriptional switch mediated by cofactor methylation.";
RL   Science 294:2507-2511(2001).
CC   -!- FUNCTION: Nuclear receptor coactivator that directly binds nuclear
CC       receptors and stimulates the transcriptional activities in a
CC       hormone-dependent fashion. Plays a central role in creating a
CC       multisubunit coactivator complex, probably via remodeling of
CC       chromatin. Involved in the coactivation of different nuclear
CC       receptors, such as for steroids (GR and ER), retinoids (RARs and
CC       RXRs), thyroid hormone (TRs), vitamin D3 (VDR) and prostanoids
CC       (PPARs). Displays histone acetyltransferase activity. Also
CC       involved in the coactivation of the NF-kappa-B pathway via its
CC       interaction with the NFKB1 subunit (By similarity).
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + histone = CoA + acetylhistone.
CC   -!- ENZYME REGULATION: Coactivator activity on nuclear receptors and
CC       NF-kappa-B pathways is enhanced by various hormones, and the TNF
CC       cytokine, respectively. TNF stimulation probably enhances
CC       phosphorylation, which in turn activates coactivator function. In
CC       contrast, acetylation by CREBBP apparently suppresses coactivation
CC       of target genes by disrupting its association with nuclear
CC       receptors (By similarity).
CC   -!- SUBUNIT: Interacts with the histone acetyltransferase protein
CC       CREBBP. These two proteins are present in a complex containing
CC       NCOA2, IKKA, IKKB and IKBKG. Interacts with PCAF and NR3C1 (By
CC       similarity). Interacts with CARM1. Interacts with CASP8AP2.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Nucleus (By
CC       similarity). Note=Mainly cytoplasmic and weakly nuclear. Upon TNF
CC       activation and subsequent phosphorylation, it translocates from
CC       the cytoplasm to the nucleus (By similarity).
CC   -!- TISSUE SPECIFICITY: Not expressed in all steroid sensitive
CC       tissues. Highly expressed in the female reproductive system, in
CC       both oocyte and smooth muscle cells of the oviduct, but not
CC       expressed in the uterine endometrium. Highly expressed in mammary
CC       glands. Expressed moderately in smooth muscle cells of both blood
CC       vessels and intestines, and weakly expressed in hepatocytes. In
CC       brain, highly expressed in neurons of the hyppocampus, and in
CC       mitral cell and granule layers of the olfactory bulb. Expressed
CC       moderately in the internal layer of cerebellum. Not expressed in
CC       the spinal chord, cardiac muscle, skeletal muscle, thymus and
CC       pancreas.
CC   -!- DOMAIN: Contains three Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs. Motifs
CC       1 and 2 are essential for the association with nuclear receptors,
CC       and constitute the RID domain (Receptor-interacting domain) (By
CC       similarity).
CC   -!- PTM: Acetylated by CREBBP. Acetylation occurs in the RID domain,
CC       and disrupts the interaction with nuclear receptors and regulates
CC       its function (By similarity).
CC   -!- PTM: Methylated by CARM1.
CC   -!- PTM: Phosphorylated by IKK complex. Regulated its function (By
CC       similarity).
CC   -!- MISCELLANEOUS: Defects in NCOA3 result in diverse phenotype of
CC       postnatal growth retardation, such as dwarfism, delayed puberty,
CC       abnormal reproductive fucntion and mammary gland growth
CC       retardation.
CC   -!- SIMILARITY: Belongs to the SRC/p160 nuclear receptor coactivator
CC       family.
CC   -!- SIMILARITY: Contains 1 basic helix-loop-helix (bHLH) domain.
CC   -!- SIMILARITY: Contains 1 PAS (PER-ARNT-SIM) domain.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF000581; AAC05020.1; -; mRNA.
DR   EMBL; AK021229; -; NOT_ANNOTATED_CDS; mRNA.
DR   UniGene; Mm.1011; -.
DR   HSSP; Q9Y6Q9; 1KBH.
DR   SMR; O09000; 1052-1098.
DR   PhosphoSite; O09000; -.
DR   Ensembl; ENSMUSG00000027678; Mus musculus.
DR   MGI; MGI:1276535; Ncoa3.
DR   HOVERGEN; O09000; -.
DR   ArrayExpress; O09000; -.
DR   CleanEx; MM_NCOA3; -.
DR   CleanEx; MM_RAC3; -.
DR   GermOnline; ENSMUSG00000027678; Mus musculus.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   InterPro; IPR010011; DUF1518.
DR   InterPro; IPR001092; HLH_basic.
DR   InterPro; IPR014920; Nuc_rcpt_coact_Ncoa-typ.
DR   InterPro; IPR017426; Nuclear_rcpt_coactivator.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR013767; PAS_fold.
DR   InterPro; IPR014935; SRC-1.
DR   Pfam; PF07469; DUF1518; 1.
DR   Pfam; PF08815; Nuc_rec_co-act; 1.
DR   Pfam; PF00989; PAS; 1.
DR   Pfam; PF08832; SRC-1; 1.
DR   PIRSF; PIRSF038181; Nuclear_receptor_coactivator; 1.
DR   SMART; SM00353; HLH; 1.
DR   SMART; SM00091; PAS; 1.
DR   PROSITE; PS50888; HLH; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Acyltransferase; Cytoplasm; Methylation;
KW   Nucleus; Phosphoprotein; Repeat; Transcription;
KW   Transcription regulation; Transferase.
FT   CHAIN         1   1398       Nuclear receptor coactivator 3.
FT                                /FTId=PRO_0000094407.
FT   DOMAIN       45     81       Helix-loop-helix motif.
FT   DOMAIN      111    181       PAS.
FT   DOMAIN     1104   1278       Acetyltransferase.
FT   DNA_BIND     36     44       Basic motif.
FT   REGION      949   1113       Interaction with CREBBP (By similarity).
FT   MOTIF       678    682       LXXLL motif 1.
FT   MOTIF       730    734       LXXLL motif 2.
FT   MOTIF      1041   1045       LXXLL motif 3.
FT   COMPBIAS    429    664       Ser-rich.
FT   COMPBIAS    965    987       Poly-Gln.
FT   MOD_RES     609    609       N6-acetyllysine; by CREBBP (By
FT                                similarity).
FT   MOD_RES     612    612       N6-acetyllysine; by CREBBP (By
FT                                similarity).
FT   MOD_RES     613    613       N6-acetyllysine; by CREBBP (By
FT                                similarity).
FT   MOD_RES     847    847       Phosphoserine (By similarity).
SQ   SEQUENCE   1398 AA;  151574 MW;  EF44E92735816C24 CRC64;
     MSGLGESSLD PLAAESRKRK LPCDAPGQGL VYSGEKWRRE QESKYIEELA ELISANLSDI
     DNFNVKPDKC AILKETVRQI RQIKEQGKTI SSDDDVQKAD VSSTGQGVID KDSLGPLLLQ
     ALDGFLFVVN RDGNIVFVSE NVTQYLQYKQ EDLVNTSVYS ILHEPRRKDF LNTYQNPQLM
     EFLGLMRTRD KKAPYILIVR MLMKTHDILE DVNASPETRQ RYETMQCFAL SQPRAMLEEG
     EDLQCCMICV ARRVTAPFPS SPESFITRHD LSGKVVNIDT NSLRSSMRPG FEDIIRRCIQ
     RFFSLNDGQS WSQKRHYQEA YVHGHAETPV YRFSLADGTI VSAQTKSKLF RNPVTNDRHG
     FISTHFLQRE QNGYRPNPIP QDKGIRPPAA GCGVSMSPNQ NVQMMGSRTY GVPDPSNTGQ
     MGGARYGASS SVASLTPGQS LQSPSSYQNS SYGLSMSSPP HGSPGLGPNQ QNIMISPRNR
     GSPKMASHQF SPAAGAHSPM GPSGNTGSHS FSSSSLSALQ AISEGVGTSL LSTLSSPGPK
     LDNSPNMNIS QPSKVSGQDS KSPLGLYCEQ NPVESSVCQS NSRDPQVKKE SKESSGEVSE
     TPRGPLESKG HKKLLQLLTC SSDDRGHSSL TNSPLDPNCK DSSVSVTSPS GVSSSTSGTV
     SSTSNVHGSL LQEKHRILHK LLQNGNSPAE VAKITAEATG KDTSSTASCG EGTTRQEQLS
     PKKKENNALL RYLLDRDDPS DVLAKELQPQ ADSGDSKLSQ CSCSTNPSSG QEKDPKIKTE
     TNDEVSGDLD NLDAILGDLT SSDFYNNPTN GGHPGAKQQM FAGPSSLGLR SPQPVQSVRP
     PYNRAVSLDS PVSVGSGPPV KNVSAFPGLP KQPILAGNPR MMDSQENYGA NMGPNRNVPV
     NPTSSPGDWG LANSRASRME PLASSPLGRT GADYSATLPR PAMGGSVPTL PLRSNRLPGA
     RPSLQQQQQQ QQQQQQQQQQ QQQQQQQMLQ MRTGEIPMGM GVNPYSPAVQ SNQPGSWPEG
     MLSMEQGPHG SQNRPLLRNS LDDLLGPPSN AEGQSDERAL LDQLHTFLSN TDATGLEEID
     RALGIPELVN QGQALESKQD VFQGQEAAVM MDQKAALYGQ TYPAQGPPLQ GGFNLQGQSP
     SFNSMMGQIS QQGSFPLQGM HPRAGLVRPR TNTPKQLRMQ LQQRLQGQQF LNQSRQALEM
     KMENPAGTAV MRPMMPQAFF NAQMAAQQKR ELMSHHLQQQ RMAMMMSQPQ PQAFSPPPNV
     TASPSMDGVL AGSAMPQAPP QQFPYPANYG MGQPPEPAFG RGSSPPSAMM SSRMGPSQNA
     MVQHPQPTPM YQPSDMKGWP SGNLARNGSF PQQQFAPQGN PAAYNMVHMN SSGGHLGQMA
     MTPMPMSGMP MGPDQKYC
//